Pages that link to "Q69002726"
Jump to navigation
Jump to search
The following pages link to Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation (Q69002726):
Displaying 50 items.
- The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis (Q24295283) (← links)
- Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes (Q24304321) (← links)
- Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management (Q26771818) (← links)
- FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae (Q27931207) (← links)
- Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein (Q27934061) (← links)
- The history of cyclosporin A (Sandimmune) revisited: another point of view (Q28274108) (← links)
- Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog (Q28367610) (← links)
- Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication (Q28368266) (← links)
- Intravitreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in Rats (Q28565470) (← links)
- Immunosuppressive drugs in paediatric liver transplantation (Q32060938) (← links)
- Topical pimecrolimus as a new optional treatment in cutaneous sarcoidosis of lichenoid type (Q33552277) (← links)
- Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures (Q34197184) (← links)
- Effects of rapamycin on cultured hepatocyte proliferation and gene expression (Q34240244) (← links)
- FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice (Q34240587) (← links)
- Ocular allergy treatments (Q34249336) (← links)
- FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh (Q34251607) (← links)
- Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA (Q34257082) (← links)
- FK 506 prevents spontaneous diabetes in the BB rat (Q34257088) (← links)
- FK 506 and autoimmune disease: perspective and prospects (Q34257329) (← links)
- Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. (Q34275070) (← links)
- Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors (Q34275901) (← links)
- Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy (Q34298815) (← links)
- Kidney transplantation under FK 506 (Q34302082) (← links)
- The role of small molecules in musculoskeletal regeneration (Q34346326) (← links)
- Nontraditional microbial bioactive metabolites (Q34567766) (← links)
- Tacrolimus (FK506) suppresses TREM-1 expression at an early but not at a late stage in a murine model of fungal keratitis (Q34612464) (← links)
- Calcium mobilization is both required and sufficient for initiating chromatin decondensation during activation of peripheral T-cells (Q34625889) (← links)
- Staphylococcal Enterotoxin B Causes Proliferation of Sensory C-Fibers and Subsequent Enhancement of Neurogenic Inflammation in Rat Skin (Q34764048) (← links)
- Engineering the ABA Plant Stress Pathway for Regulation of Induced Proximity (Q35031343) (← links)
- FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells (Q35042532) (← links)
- Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis (Q35226825) (← links)
- The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine (Q35588481) (← links)
- A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. (Q36094936) (← links)
- Tacrolimus: in patients with rheumatoid arthritis (Q36126516) (← links)
- Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens (Q36230333) (← links)
- The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin (Q36231731) (← links)
- Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology (Q36362044) (← links)
- Impairment of early fracture healing by skeletal muscle trauma is restored by FK506. (Q36399620) (← links)
- Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis (Q36596448) (← links)
- Platelet activating factor synthesis and metabolism in intestinal ischaemia-reperfusion injury (Q36627635) (← links)
- Interpreting tacrolimus concentrations during pregnancy and postpartum. (Q36799909) (← links)
- Neisseria meningitidis encodes an FK506-inhibitable rotamase (Q36825355) (← links)
- The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms (Q37091570) (← links)
- Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12 (Q37199196) (← links)
- KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer (Q37224269) (← links)
- Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells (Q37362163) (← links)
- Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients (Q37439873) (← links)
- The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1 (Q38334131) (← links)
- Management of High-risk Corneal Transplantation (Q38778422) (← links)
- Systemic Immunomodulatory Strategies in High-risk Corneal Transplantation (Q38904800) (← links)